What are Bioventus's profit margins?

Bioventus (BVS) runs a 68.7% gross margin and a 10.0% operating margin, with a 4.9% net margin.

Where do Bioventus's ratios come from?

Every ratio is computed from Bioventus's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Bioventus BVS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	68.7%+1.2pp	68.3%+0.6pp	67.8%+0.8pp	67.6%+1.1pp	67.4%+1.9pp
Operating margin	10%—	9.5%—	——	——	——
Net margin	4.9%+10.9pp	4%+10.3pp	1.3%+8.9pp	-0.1%+8.1pp	-6%-1.8pp
EBITDA margin	18%+14.9pp	17.8%+14.7pp	13%+8.2pp	11.8%+6.7pp	3.1%-9.7pp
Free cash flow margin	17.5%+13.2pp	12.7%+6.1pp	9.5%+4.3pp	6%+4.5pp	4.2%+3.7pp
Returns
Return on equity	16.9%+38.1pp	13.7%+36.2pp	4.8%+30.5pp	-0.5%+25.9pp	-21.2%-9.0pp
Return on assets	4.2%+8.8pp	3.2%+7.9pp	1%+6.3pp	-0.1%+5.3pp	-4.6%-1.9pp
Return on invested capital	12.3%+18.4pp	11.9%+18.2pp	5.2%+9.4pp	3.5%+7.9pp	-6.1%-8.5pp
Efficiency
Asset turnover	0.9×+0.1×	0.8×+0.1×	0.8×+0.1×	0.8×+0.1×	0.8×+0.1×
Inventory turnover	2×+0.1×	2.1×0.0×	2×0.0×	2×+0.1×	1.9×0.0×
Liquidity
Current ratio	1.7×+0.3×	1.7×+0.4×	1.7×+0.3×	1.5×+0.1×	1.4×-0.1×
Quick ratio	1.1×+0.2×	1.2×+0.3×	1.1×+0.2×	1×0.0×	0.9×-0.1×
Cash ratio	0.2×+0.1×	0.3×+0.1×	0.3×+0.1×	0.2×0.0×	0.1×0.0×
Leverage
Debt-to-equity	1.5×-0.9×	1.7×-0.7×	2.1×-0.7×	2.2×-0.5×	2.5×0.0×
Debt-to-assets	0.4×-0.1×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Net debt / EBITDA	2.4×-17.0×	2.6×-15.3×	4.1×-9.5×	4.9×-8.9×	19.5×+13.6×
Per Share
Book value per share	$2.70+20.2%	$2.67+16.6%	$2.41+5.9%	$2.35-0.2%	$2.24-17.0%
Valuation
Market capitalization	$659.19M+51.7%	$498.3M-27.4%	$447.51M-41.5%	$448.58M+23.1%	$605.34M+83.7%
Enterprise value	$911.76M+17.2%	$758.41M-24.2%	$746.51M-33.8%	$776.32M+5.2%	$948.66M+31.7%
Price / earnings	23.1×—	21.9×—	59×—	——	——
Price / sales	1.1×+0.4×	0.9×-0.3×	0.8×-0.6×	0.8×+0.1×	1.1×+0.4×
Price / book	3.5×+0.6×	2.7×-1.9×	2.7×-2.5×	2.8×+0.4×	4.1×+2.2×
EV / EBITDA	8.8×-35.4×	7.5×-49.3×	10.2×-32.0×	11.7×-15.6×	53.8×+43.0×
EV / sales	1.6×+0.2×	1.3×-0.4×	1.3×-0.7×	1.4×0.0×	1.7×+0.3×
Free cash flow yield	15.3%+9.8pp	14.5%+9.0pp	11.9%+8.2pp	7.6%+5.3pp	4%+3.1pp
Earnings yield	4.3%+12.1pp	4.6%+9.8pp	1.7%+7.2pp	-0.2%+11.9pp	-5.6%+1.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bioventus.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bioventus's profit margins?: Bioventus (BVS) runs a 68.7% gross margin and a 10.0% operating margin, with a 4.9% net margin.
Where do Bioventus's ratios come from?: Every ratio is computed from Bioventus's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.